Long Wavelength Light Activated Prodrug Conjugates for Biomedical Applications

Yutong Hou,Zhiguo Zhou,Kai Huang,Hong Yang,Gang Han
DOI: https://doi.org/10.1002/cptc.201800147
2018-01-01
ChemPhotoChem
Abstract:Long wavelength light (LWL) activated prodrug conjugates are a promising system to prevent systemic side effects and reduce drug resistance in cancer therapy. These systems have been applied for spatiotemporal‐ and dose‐controlled drug release under low‐energy LWL irradiation. Compared with other drug release systems, LWL‐activated prodrug conjugates offer deep‐tissue cancer therapies at the desired site and time with excitation only by LWL. Therefore, the fabrication of LWL‐activated prodrug conjugates is highly important. To achieve this goal, a LWL transducer that could convert LWL into an on‐demand stimulus for prodrug activation was proposed. This Minireview summarizes the latest developments of light transduction and the application in LWL‐activated prodrug conjugates for biomedical applications.
What problem does this paper attempt to address?